Blood tests to predict outcomes in hellp syndrome
Part of Women’s health & pregnancy clinical trials.
This study looks at blood tests (platelet counts and inflammation markers) in women with HELLP syndrome, a serious pregnancy condition. The goal is to see if these blood levels can help predict how the disease will progress, which could lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant, between 18 and 45 years old, and at 28 to 41 weeks of pregnancy.
- You have been diagnosed with HELLP syndrome or preeclampsia with HELLP.
- Your baby is a single fetus (not twins or more) with no known birth defects.
- You do not have current infection, fever, diabetes, high blood pressure, or chronic kidney, liver, or blood disorders.
- You are not taking medications that affect platelets, and your water has not broken early.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood-flow and artery health signs during pregnancy to better understand why preeclampsia happens. It compares women with preeclampsia to women with an uncomplicated pregnancy, and may help improve early detection and care.
This study is testing a new blood test that might help doctors quickly and safely identify preeclampsia, a serious pregnancy condition. If you're at risk, this test could help you get the right care earlier.
This study tests a new approach to prevent long-term heart and kidney problems in people who had preeclampsia, HELLP syndrome, or kidney disease during pregnancy. It aims to see if early follow-up care can improve future health.
This study looks at a blood marker called sCD163 in pregnant women with and without HELLP syndrome, a severe pregnancy complication. It aims to see if this marker helps diagnose or track the condition.
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
This study looks at blood vessel function in pregnant people with preeclampsia to see if it can help predict outcomes. It involves non-invasive measures and routine blood tests.
Hear when a new HELLP Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.